These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Multimodal approach to the endovascular treatment of embolisation or exclusion of the renal arteries and their distal and/or polar branches: personal experience. Pozzi-Mucelli F, Medeot A, Cernic S, Calgaro A, Braini M, Cova M. Radiol Med; 2011 Sep; 116(6):945-59. PubMed ID: 21509547 [Abstract] [Full Text] [Related]
55. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM. J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825 [Abstract] [Full Text] [Related]
56. [Improvement in the prognosis of renal cell carcinoma by percutaneous transvascular embolization]. Stösslein F, Schwenke A, Münster W, Köhler H, Mebel M, Raatzsch H, Steude U, Krosegk G. Z Urol Nephrol; 1987 Oct; 80(10):577-86. PubMed ID: 3433986 [Abstract] [Full Text] [Related]